Concepts of Designing and Implementing Pharmacoepidemiology Studies on the Safety of Systemic Treatments in Dermatology Practice by Sebastian Schneeweiss, Maria C. Schneeweiss

Get full text

Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions by Shirley V. Wang, Sushama Kattinakere Sreedhara, Sebastian Schneeweiss, REPEAT Initiative

Get full text

Dimension reduction and shrinkage methods for high dimensional disease risk scores in historical data by Hiraku Kumamaru, Sebastian Schneeweiss, Robert J. Glynn, Soko Setoguchi, Joshua J. Gagne

Get full text

Desmopressin and the risk of hyponatremia: A population-based cohort study. by Michael Fralick, Sebastian Schneeweiss, Christopher J D Wallis, Emily H Jung, Aaron S Kesselheim

Get full text

Rosiglitazone and myocardial infarction in patients previously prescribed metformin. by Colin R Dormuth, Malcolm Maclure, Greg Carney, Sebastian Schneeweiss, Ken Bassett, James M Wright

Get full text

Prescribing Trends of Oral Anticoagulants in US Patients With Cirrhosis and Nonvalvular Atrial Fibrillation by Tracey G. Simon, Sebastian Schneeweiss, Daniel E. Singer, Sushama Kattinakere Sreedhara, Kueiyu Joshua Lin

Get full text

A novel data mining application to detect safety signals for newly approved medications in routine care of patients with diabetes by Michael Fralick, Martin Kulldorff, Donald Redelmeier, Shirley V. Wang, Seanna Vine, Sebastian Schneeweiss, Elisabetta Patorno

Get full text

Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results by Kevin Wing, Elizabeth Williamson, James R Carpenter, Lesley Wise, Sebastian Schneeweiss, Liam Smeeth, Jennifer K Quint, Ian Douglas

Get full text

The influence of the COVID-19 pandemic on the prescription of multiple sclerosis medication in Germany by Jonathan Orschiedt, Elizabeth Jacyshyn-Owen, Maria Kahn, Sven Jansen, Natalie Joschko, Markus Eberl, Sebastian Schneeweiss, Benjamin Friedrich, Tjalf Ziemssen

Get full text

The IMPACT of the COVID-19 Pandemic on Prescription Drug Use in Patients with Psoriasis Vulgaris in Germany by Maria Kahn, Steffeni Papukchieva, Elizabeth Jacyshyn-Owen, Stefan Grimm, Markus Eberl, Sebastian Schneeweiss, Marina Otten, Matthias Augustin, Benjamin Friedrich

Get full text

Safety and Effectiveness of Direct Oral Anticoagulants Versus Vitamin K Antagonists: Pilot Implementation of a Near‐Real‐Time Monitoring Program in Italy by Flavia Mayer, Ursula Kirchmayer, Paola Coletta, Nera Agabiti, Valeria Belleudi, Giovanna Cappai, Mirko Di Martino, Sebastian Schneeweiss, Marina Davoli, Elisabetta Patorno

Get full text

Durability of Protection Post–Primary COVID-19 Vaccination in the United States by Amanda Zheutlin, Miles Ott, Ran Sun, Natalia Zemlianskaia, Craig S. Meyer, Meagan Rubel, Jennifer Hayden, Breno Neri, Tripthi Kamath, Najat Khan, Sebastian Schneeweiss, Khaled Sarsour

Get full text

Linking the Paul Coverdell National Acute Stroke Program to commercial claims to establish a framework for real-world longitudinal stroke research by Ajinkya Pawar, Sebastian Schneeweiss, Jessica M Franklin, Xin Tong, Mary G George, Lee H Schwamm, Helen Mogun, Elisabetta Patorno, Lidia M V R Moura

Get full text

The EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study programme: Design and exposure accrual for an evaluation of empagliflozin in routine clinical care by Elisabetta Patorno, Mehdi Najafzadeh, Ajinkya Pawar, Jessica M. Franklin, Anouk Déruaz‐Luyet, Kimberly G. Brodovicz, Adrian J. Santiago Ortiz, Lily G. Bessette, Martin Kulldorff, Sebastian Schneeweiss

Get full text

Correction: Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study by Phyo T. Htoo, Helen Tesfaye, Sebastian Schneeweiss, Deborah J. Wexler, Brendan M. Everett, Robert J. Glynn, Niklas Schmedt, Lisette Koeneman, Anouk Déruaz-Luyet, Julie M. Paik, Elisabetta Patorno

Get full text

Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study by Phyo T. Htoo, Helen Tesfaye, Sebastian Schneeweiss, Deborah J. Wexler, Brendan M. Everett, Robert J. Glynn, Niklas Schmedt, Lisette Koeneman, Anouk Déruaz-Luyet, Julie M. Paik, Elisabetta Patorno

Get full text

Broadening the reach of the FDA Sentinel system: A roadmap for integrating electronic health record data in a causal analysis framework by Rishi J. Desai, Michael E. Matheny, Kevin Johnson, Keith Marsolo, Lesley H. Curtis, Jennifer C. Nelson, Patrick J. Heagerty, Judith Maro, Jeffery Brown, Sengwee Toh, Michael Nguyen, Robert Ball, Gerald Dal Pan, Shirley V. Wang, Joshua J. Gagne, Sebastian Schneeweiss

Get full text

Development of the TrAnsparent ReportinG of observational studies Emulating a Target trial (TARGET) guideline by Sallie-Anne Pearson, Sebastian Schneeweiss, James H McAuley, Jonathan Sterne, Elizabeth A Stuart, Miguel A Hernán, Hopin Lee, Sonja A Swanson, Matthias Egger, Melissa K Sharp, Aidan G Cashin, Nazrul Islam, Matthew D Jones, Issa J Dahabreh, Sara Lodi, Robert M Golub, Harrison J Hansford, Margarita Moreno-Betancur, Barbra A Dickerman, Xavier Garcia-Albeniz

Get full text